Edwards Historical Cash Flow

EW Stock  USD 95.15  1.73  1.85%   
Analysis of Edwards Lifesciences cash flow over time is an excellent tool to project Edwards Lifesciences Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 81.8 M or Other Non Cash Items of 10 M as it is a great indicator of Edwards Lifesciences ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Edwards Lifesciences Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Edwards Lifesciences Corp is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

About Edwards Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Edwards balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Edwards's non-liquid assets can be easily converted into cash.

Edwards Lifesciences Cash Flow Chart

Edwards Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Edwards Lifesciences Corp Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Edwards Lifesciences' Net Income is fairly stable compared to the past year. Change In Cash is likely to climb to about 394.2 M in 2024, whereas Free Cash Flow is likely to drop slightly above 444.3 M in 2024.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Capital Expenditures

Capital Expenditures are funds used by Edwards Lifesciences Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Edwards Lifesciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Edwards Lifesciences Corp financial statement analysis. It represents the amount of money remaining after all of Edwards Lifesciences Corp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Edwards Lifesciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
At this time, Edwards Lifesciences' Net Income is fairly stable compared to the past year. Change In Cash is likely to climb to about 394.2 M in 2024, whereas Free Cash Flow is likely to drop slightly above 444.3 M in 2024.

Edwards Lifesciences cash flow statement Correlations

-0.030.85-0.48-0.39-0.27-0.62-0.46-0.61-0.75-0.230.430.660.23-0.570.270.060.070.16-0.690.050.33-0.78
-0.030.080.610.050.630.71-0.210.530.360.750.35-0.36-0.13-0.55-0.34-0.2-0.09-0.180.620.08-0.130.29
0.850.08-0.48-0.42-0.18-0.6-0.48-0.39-0.760.020.660.540.44-0.570.530.180.170.1-0.640.090.49-0.78
-0.480.61-0.480.10.690.78-0.090.490.810.62-0.22-0.6-0.15-0.12-0.4-0.17-0.32-0.40.75-0.2-0.220.76
-0.390.05-0.420.10.260.150.220.260.190.14-0.47-0.340.060.57-0.11-0.49-0.20.270.140.730.060.13
-0.270.63-0.180.690.260.62-0.080.730.490.88-0.26-0.450.3-0.13-0.08-0.23-0.16-0.140.640.280.330.53
-0.620.71-0.60.780.150.620.170.750.850.61-0.14-0.64-0.36-0.08-0.57-0.22-0.19-0.290.98-0.15-0.390.79
-0.46-0.21-0.48-0.090.22-0.080.170.430.22-0.29-0.340.1-0.220.44-0.150.1-0.130.70.260.04-0.130.4
-0.610.53-0.390.490.260.730.750.430.60.71-0.15-0.420.010.09-0.2-0.12-0.20.080.810.160.060.67
-0.750.36-0.760.810.190.490.850.220.60.39-0.41-0.59-0.290.17-0.47-0.26-0.4-0.350.87-0.21-0.350.87
-0.230.750.020.620.140.880.61-0.290.710.390.11-0.480.23-0.25-0.06-0.19-0.12-0.340.60.190.230.38
0.430.350.66-0.22-0.47-0.26-0.14-0.34-0.15-0.410.110.18-0.23-0.55-0.020.240.17-0.14-0.24-0.15-0.23-0.45
0.66-0.360.54-0.6-0.34-0.45-0.640.1-0.42-0.59-0.480.180.12-0.340.230.09-0.030.38-0.60.080.34-0.42
0.23-0.130.44-0.150.060.3-0.36-0.220.01-0.290.23-0.230.120.00.870.030.080.13-0.270.250.95-0.28
-0.57-0.55-0.57-0.120.57-0.13-0.080.440.090.17-0.25-0.55-0.340.00.06-0.26-0.170.21-0.020.17-0.080.15
0.27-0.340.53-0.4-0.11-0.08-0.57-0.15-0.2-0.47-0.06-0.020.230.870.060.190.310.14-0.490.180.76-0.44
0.06-0.20.18-0.17-0.49-0.23-0.220.1-0.12-0.26-0.190.240.090.03-0.260.190.460.16-0.21-0.34-0.02-0.13
0.07-0.090.17-0.32-0.2-0.16-0.19-0.13-0.2-0.4-0.120.17-0.030.08-0.170.310.46-0.09-0.170.150.0-0.19
0.16-0.180.1-0.40.27-0.14-0.290.70.08-0.35-0.34-0.140.380.130.210.140.16-0.09-0.270.290.25-0.22
-0.690.62-0.640.750.140.640.980.260.810.870.6-0.24-0.6-0.27-0.02-0.49-0.21-0.17-0.27-0.14-0.290.86
0.050.080.09-0.20.730.28-0.150.040.16-0.210.19-0.150.080.250.170.18-0.340.150.29-0.140.34-0.16
0.33-0.130.49-0.220.060.33-0.39-0.130.06-0.350.23-0.230.340.95-0.080.76-0.020.00.25-0.290.34-0.28
-0.780.29-0.780.760.130.530.790.40.670.870.38-0.45-0.42-0.280.15-0.44-0.13-0.19-0.220.86-0.16-0.28
Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(105.4M)(120.6M)19M(213.4M)(289M)(274.6M)
Free Cash Flow901M647M1.4B953.4M629.5M444.3M
Change In Working Capital(204.3M)42.2M145.3M(421.4M)(526.3M)(500.0M)
Other Cashflows From Financing Activities35M155.5M163.5M142.8M168.9M160.5M
Depreciation89.3M107.2M134.8M139.6M144.9M81.8M
Other Non Cash Items154.1M38.3M(119M)105.8M10.5M10.0M
Capital Expenditures278.4M407.3M329.8M264.8M266.3M146.6M
Total Cash From Operating Activities1.2B1.1B1.7B1.2B895.8M590.9M
Net Income1.0B823.4M1.5B1.5B1.4B1.5B
Total Cash From Financing Activities(115.6M)(486.9M)(356.3M)(1.6B)(711M)(675.5M)
Change In Cash465M15.8M(332.8M)(94.8M)375.4M394.2M
End Period Cash Flow1.2B1.2B867.4M772.6M1.1B1.2B
Other Cashflows From Investing Activities(183.2M)(22.4M)(61.5M)517.1M465.4M488.7M
Stock Based Compensation81.3M92.6M109.3M126.8M139.4M146.4M
Begin Period Cash Flow714.1M1.2B1.2B867.4M772.6M499.0M
Change To Liabilities(20.3M)(137.4M)257.2M(27M)(31.1M)(29.5M)
Sale Purchase Of Stock(263.3M)(625.4M)(512.8M)(1.7B)(879.6M)(835.6M)
Change To Account Receivables(94.8M)283.9M(112.4M)(84.1M)(141.2M)(134.1M)
Total Cashflows From Investing Activities(595.8M)(531.1M)(1.7B)252.3M227.1M238.4M
Dividends Paid18.9M(140.5M)(158.6M)(146.4M)(169.9M)(161.4M)
Investments(158.2M)(101.7M)(1.3B)252.3M254.4M267.1M
Change Receivables(88M)41.9M(91.1M)(84.1M)(75.7M)(71.9M)
Net Borrowings(10M)(800K)(1.8M)(200K)(180K)(171K)
Cash And Cash Equivalents Changes468M36.3M(346.7M)(114M)(102.6M)(97.5M)
Cash Flows Other Operating1.1B1.1B1.5B1.5B1.7B1.8B
Change To Netincome198.2M53.3M(79.6M)(49.1M)(56.5M)(53.6M)
Change To Operating Activities9.4M258.3M(39.8M)(96.9M)(87.2M)(82.8M)

Edwards Lifesciences Investors Sentiment

The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Edwards Stock

  0.86SSY SunLink Health SystemsPairCorr
  0.69TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.65DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.65FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.62NEOG Neogen Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.3
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.